OZETTE

Serial Number 97374157
733

Registration Progress

Application Filed
Apr 21, 2022
Under Examination
Aug 22, 2023
Approved for Publication
Jun 27, 2023
Published for Opposition
Jun 27, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 4 Granted
Due: Feb 22, 2026 106 days

Trademark Image

OZETTE

Basic Information

Serial Number
97374157
Filing Date
April 21, 2022
Published for Opposition
June 27, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
Aug 13, 2025
Application
Pending
Classes
001 005 009 010

Rights Holder

Ozette Technologies, Inc.

03
Address
1522 Western Ave, Ste 24206
Seattle, WA 98101

Ownership History

Ozette Technologies, Inc.

Original Applicant
03
Seattle, WA

Ozette Technologies, Inc.

Owner at Publication
03
Seattle, WA

Legal Representation

Attorney
Chelsea E. Carbone

USPTO Deadlines

Next Deadline
106 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
February 22, 2026
Extension Available
Until August 22, 2024

Application History

39 events
Date Code Type Description Documents
Aug 13, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 13, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Aug 11, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 10, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 15, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 14, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 12, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 12, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 14, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 14, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 14, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 14, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 23, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 23, 2024 NOAC E CORRECTED NOA E-MAILED Loading...
Mar 22, 2024 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Mar 22, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 29, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 6, 2024 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Feb 6, 2024 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Feb 5, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 5, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 22, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 27, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 27, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 7, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 25, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 25, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 25, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
May 25, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
May 25, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 24, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 22, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 22, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 23, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 23, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 23, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 8, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 27, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 25, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Chemical test kits for diagnosing, monitoring, and treating infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders for laboratory or research use; assays for research purposes; assays for testing blood and other bodily fluids for research purposes; assays and reagents for use in infectious disease, oncology, autoimmunity, cardiovascular, and neurological disorders research
Class 005
Medical diagnostic reagents and assays for testing and analyzing blood and other bodily fluids; diagnostic kits comprised of medical diagnostic reagents and assays for testing of blood and other bodily fluids for use in disease and disorder detection, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; pharmaceutical preparations for use in treating infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; drug testing kits comprised of medical diagnostic reagents and assays for testing blood and other bodily fluids; diagnostic reagents for medicinal use
Class 009
Downloadable computer software using artificial intelligence (AI) and machine learning for analysis of immune data for the purposes of medical research, diagnosis, and treatment; downloadable computer software using artificial intelligence (AI) and machine learning for analysis of immune data for the purposes of identifying, prescribing, and monitoring medications; downloadable computer software using artificial intelligence (AI) and machine learning for diagnosing, monitoring, and treating diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; software as a Medical Device (SaMD), downloadable, for analyzing the immune system for the purposes of medical diagnosis and treatment; software as a Medical Device (SaMD), downloadable, for analyzing the immune system for the purposes of identifying, prescribing and monitoring medications; software as a Medical Device (SaMD), downloadable, for diagnosing, monitoring and treating diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; computer hardware; computer hardware with imbedded software for diagnosing, monitoring, and treating diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids
Class 010
Medical device for detecting diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; medical device, namely, medical device for disease and disorder diagnosis, monitoring of biological material and cell populations, and medical treatment device in the nature of medical devices for the interrogation of biological samples; medical devices for detection and treatment of infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; apparatus for blood analysis; apparatus for taking blood samples; blood collection kit comprised of medical tubes and vials, tube and vial holders, and transportation device and blood testing apparatus; medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of infectious disease, oncology, autoimmunity, cardiovascular, and neurological disorders; laboratory apparatus, namely, diagnostic apparatus for the interrogation of biological samples featuring artificial intelligence (AI) and machine learning recorded software for medical diagnosis, monitoring, and treatment of diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; laboratory apparatus, namely, diagnostic apparatus for the interrogation of biological samples featuring artificial intelligence (AI) and machine learning recorded software for monitoring the immune system for the purposes of identifying, prescribing, and monitoring medications; laboratory apparatus and instruments in the nature of medical devices and diagnostic apparatus for the interrogation of biological samples for diagnosing diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders

Classification

International Classes
001 005 009 010